Evidence map›Paper›PMID 18154660›Full record

ArticleTheoretical biology & medical modelling2007

Simulating non-small cell lung cancer with a multiscale agent-based model.

Zhihui Wang, Le Zhang, Jonathan Sagotsky, Thomas S Deisboeck

Abstract read
In one paragraph

Article in Theoretical biology & medical modelling, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. A multi-layered hybrid model for cancer cell invasion.Medical & biological engineering & computing · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Multi-scale models of lung fibrosis.Matrix biology : journal of the International Society for Matrix Biology · 2020
    Review
  11. A Multiscale Agent-Based Model of Ductal Carcinoma In Situ.IEEE transactions on bio-medical engineering · 2020
    Article
  12. Review
  13. Article
  14. Article
  15. Dynamic Targeting in Cancer Treatment.Frontiers in physiology · 2019
    Article
  16. A HYBRID THREE-SCALE MODEL OF TUMOR GROWTH.Mathematical models & methods in applied sciences : M3AS · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Integrated PK-PD and agent-based modeling in oncology.Journal of pharmacokinetics and pharmacodynamics · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhihui WangComplex Biosystems Modeling Laboratory, Harvard-MIT (HST) Athinoula A, Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA 02129, USA. billwang@nmr.mgh.harvard.edu
Le Zhang
Jonathan Sagotsky
Thomas S Deisboeck

Funding

Subproject OneU56CA113004 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DEISBOECK, THOMAS S · 2004 to 2009
$3.4M
NCI NIH HHS CA 113004NCI NIH HHS U56 CA113004
6 · The paper itself

Abstract

backgroundThe epidermal growth factor receptor (EGFR) is frequently overexpressed in many cancers, including non-small cell lung cancer (NSCLC). In silico modeling is considered to be an increasingly promising tool to add useful insights into the dynamics of the EGFR signal transduction pathway. However, most of the previous modeling work focused on the molecular or the cellular level only, neglecting the crucial feedback between these scales as well as the interaction with the heterogeneous biochemical microenvironment.

resultsWe developed a multiscale model for investigating expansion dynamics of NSCLC within a two-dimensional in silico microenvironment. At the molecular level, a specific EGFR-ERK intracellular signal transduction pathway was implemented. Dynamical alterations of these molecules were used to trigger phenotypic changes at the cellular level. Examining the relationship between extrinsic ligand concentrations, intrinsic molecular profiles and microscopic patterns, the results confirmed that increasing the amount of available growth factor leads to a spatially more aggressive cancer system. Moreover, for the cell closest to nutrient abundance, a phase-transition emerges where a minimal increase in extrinsic ligand abolishes the proliferative phenotype altogether.

conclusionOur in silico results indicate that in NSCLC, in the presence of a strong extrinsic chemotactic stimulus (and depending on the cell's location) downstream EGFR-ERK signaling may be processed more efficiently, thereby yielding a migration-dominant cell phenotype and overall, an accelerated spatio-temporal expansion rate.

Indexed as

Computer SimulationModels, BiologicalAlgorithmsCarcinoma, Non-Small-Cell LungEpidermal Growth FactorExtracellular Signal-Regulated MAP KinasesGene Expression Regulation, NeoplasticKineticsEpidermal Growth FactorExtracellular Signal-Regulated MAP Kinases

Identifiers

PMID18154660
PMCPMC2259313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.